|
Market Closed -
Nasdaq
21:00:00 23/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 2.130 USD | -1.84% |
|
-8.97% | -37.54% |
| 08-06 | B. Riley Adjusts Price Target on LifeMD to $8 From $10, Maintains Buy Rating | MT |
| 08-05 | LifeMD, Inc., Q2 2026 Earnings Call, Aug 05, 2026 |
Company Valuation: LifeMD, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 118.4 | 61.01 | 325 | 214.4 | 164.1 | 104.6 | - | - |
| Change | - | -48.47% | 432.67% | -34.03% | -23.44% | -36.28% | - | - |
| Enterprise Value (EV) | 77.74 | 61.01 | 325 | 214.4 | 164.1 | 104.6 | 104.6 | 104.6 |
| Change | - | -21.52% | 432.67% | -34.03% | -23.44% | -36.28% | 0% | 0% |
| P/E | -1.69x | -1.24x | -11.8x | -9.34x | -19.5x | -4.11x | -23.3x | 14x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0x | 0.2x | 0.4x | 0.3x | -0x | 0.3x | -0x |
| Capitalization / Revenue | 1.27x | 0.51x | 2.13x | 1.01x | 0.85x | 0.5x | 0.43x | 0.37x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 0.5x | 0.43x | 0.37x |
| EV / EBITDA | -0x | -0x | 0x | 0x | 0x | -26.3x | 5.24x | 3.11x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -4.81x | -137x | 8.18x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -2.29 | -1.57 | -0.7 | -0.53 | -0.1753 | -0.5186 | -0.0914 | 0.152 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 92.88 | 119 | 152.5 | 212.5 | 194.1 | 207.6 | 245.1 | 282 |
| EBITDA 1 | -38.28 | -14.66 | 11.98 | 14.38 | 15.25 | -3.976 | 19.96 | 33.6 |
| EBIT 1 | -54.3 | -43.45 | -14.49 | -16.14 | -7.67 | -21.74 | -0.761 | 12.79 |
| Net income 1 | -61.77 | -48.64 | -23.7 | -21.99 | -7.913 | -24.81 | -4.545 | 7.722 |
| Net Debt | -40.66 | - | - | - | - | - | - | - |
| Reference price 2 | 3.870 | 1.940 | 8.290 | 4.950 | 3.410 | 2.130 | 2.130 | 2.130 |
| Nbr of stocks (in thousands) | 30,593 | 31,450 | 39,203 | 43,312 | 48,136 | 48,201 | - | - |
| Announcement Date | 07/03/22 | 22/03/23 | 11/03/24 | 10/03/25 | 09/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.18x | - | - | - | 103M | |
| 34.5x | 5.88x | 22.44x | 0.27% | 250B | |
| 37.62x | 6.94x | 21.77x | 0.63% | 162B | |
| 50.11x | 12.36x | 26.64x | -.--% | 154B | |
| 17.47x | 3.46x | 11.19x | -.--% | 66.68B | |
| 20.45x | 2.45x | 12.39x | 2.47% | 52.08B | |
| 49.38x | 12.24x | 26.98x | -.--% | 52.22B | |
| 35.71x | 7.14x | 22.67x | -.--% | 51.93B | |
| 33.88x | 6.71x | 22.84x | 0.59% | 49.02B | |
| 79.76x | 7.59x | 23.04x | -.--% | 44.76B | |
| Average | 35.47x | 7.20x | 21.11x | 0.44% | 88.24B | |
| Weighted average by Cap. | 38.89x | 7.40x | 21.94x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- LFMD Stock
- Valuation LifeMD, Inc.
Select your edition
All financial news and data tailored to specific country editions
